Abivax
stock3 TerminalDu willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen
Abivax Kurse
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit |
|---|---|---|---|---|---|
| Nasdaq | |||||
| Nasdaq Basic | |||||
| Cboe BZX |
Wertentwicklung (Nasdaq)
-1,81 %
Intraday
-12,65 %
1 Woche
-17,14 %
1 Monat
-18,46 %
Seit Jahresbeginn
-18,16 %
1 Jahr
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)8,51-17,02
- Jahrestief / Hoch ($)8,51-17,02
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Beschreibung
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.
